STOCK TITAN

GKOS insider sale: 517 shares from restricted stock vesting, prior 5,142-share sale noted

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Form 144 notice for Glaukos Corp (GKOS) reports a proposed sale of 517 restricted common shares by a person whose securities vested on 09/19/2024 and were acquired as compensation. The broker listed is Fidelity Brokerage Services LLC and the aggregate market value of the proposed sale is $43,541.07 with an approximate sale date of 09/22/2025 on the NYSE. The filing also discloses that the same person sold 5,142 common shares on 09/11/2025 for gross proceeds of $453,607.98. The notice includes the standard representation that the seller does not possess undisclosed material adverse information about the issuer.

Positive

  • Disclosure complies with Rule 144 by identifying acquisition method (restricted stock vesting) and compensation payment
  • Broker and market details provided (Fidelity, NYSE) enabling clear transaction routing

Negative

  • Limited context on materiality: filing does not disclose insider's total holdings or percentage ownership to assess impact
  • No Rule 10b5-1 plan date provided in the visible remarks, so reliance on such a plan cannot be verified from this notice

Insights

TL;DR: Insider sale of vested restricted shares is routine and modest relative to company size; prior larger sale noted.

The filing shows a small proposed sale of 517 shares resulting from restricted stock vesting on 09/19/2024, valued at $43,541.07, executed through Fidelity with an approximate sale date of 09/22/2025. A prior sale by the same individual of 5,142 shares on 09/11/2025 generated $453,607.98. These disclosures are typical for insiders monetizing vested compensation and do not by themselves indicate company-operational issues. The amounts should be compared to the insider's total holdings and company market capitalization for materiality, information not provided in this notice.

TL;DR: Form 144 properly documents a planned sale tied to compensation vesting; disclosure aligns with Rule 144 requirements.

The document identifies the nature of acquisition as Restricted Stock Vesting and the payment nature as Compensation, which supports compliance with Rule 144 sale notice rules. The seller attests to absence of undisclosed material information. The filing does not state any trading-plan adoption date under Rule 10b5-1, and no further governance concerns are raised within the provided content.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 for Glaukos (GKOS) report?

It reports a proposed sale of 517 vested restricted common shares acquired 09/19/2024, valued at $43,541.07, with an approximate sale date of 09/22/2025.

Who is the broker handling the proposed sale in the GKOS Form 144?

The broker listed is Fidelity Brokerage Services LLC (900 Salem Street, Smithfield, RI).

Did the insider sell any GKOS shares recently before this proposed sale?

Yes, the notice discloses a sale of 5,142 common shares on 09/11/2025 with gross proceeds of $453,607.98.

What was the nature of acquisition for the shares to be sold?

The shares were acquired through Restricted Stock Vesting and paid as Compensation on 09/19/2024.

Does the Form 144 state the seller has undisclosed material information about Glaukos?

The seller represents by signing the notice that they do not know any material adverse information about the issuer that has not been publicly disclosed.
Glaukos Corp

NYSE:GKOS

GKOS Rankings

GKOS Latest News

GKOS Latest SEC Filings

GKOS Stock Data

6.52B
55.54M
3.31%
107.34%
5.9%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
ALISO VIEJO